IDEXX Laboratories, Inc. IDXX is well-poised to grow in the upcoming quarters due to the strong momentum in its CAG (Companion Animal Group) Diagnostics business. The company is also growing its ...

Fundsmith, an investment management firm based in London, has released its annual 2025 investor letter for its “Fundsmith ...

While they might not represent the most exciting field in the biotech space, animal healthcare companies have been a steady, consistent source of growth in what's often a turbulent market. One company ...

Image quality comparison between ImageVue DR50 and ImageVue DR50 Plus Radiography is a standard diagnostic technique in ...

Since joining IDEXX in 2011, he has held senior positions across key portions of the Company's business, including ...

IDEXX Laboratories has designated Michael Erickson to succeed Jonathan Mazelsky at the helm of the pet healthcare company later this year.

IDEXX Laboratories, a leader in pet diagnostic and software products, is targeting 10%+ organic sales growth and 15-20% EPS growth, making it a high-quality company. The company is focusing on ...

In the latest quarter, 4 analysts provided ratings for IDEXX Laboratories (NASDAQ:IDXX), showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, ...

Palo Alto and IDEXX both gained during the Wednesday session, while Capital One Financial and the Materials Select Sector ...

If you are wondering whether IDEXX Laboratories is still fairly priced after a strong run, this article walks through what the current share price could mean for long term investors. The stock last ...

IDEXX Laboratories, Inc. is a U.S. healthcare company, that currently leads the veterinary industry developing diagnostics tools to satisfy veterinarians’ everyday needs. IDEXX has delivered solid and ...

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results. Third Quarter Results The Company ...